Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishal Ranpura

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
JAMA|February 3, 2011
Treatment-related mortality with bevacizumab in cancer patients: a meta-analysisVishal Ranpura, Sanjaykumar Hapani, Shenhong Wu
Acta Oncologica (Stockholm, Sweden)|February 17, 2010
Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trialsVishal Ranpura, Sanjaykumar Hapani, Jeff Chuang, et al.
The Permanente Journal|March 29, 2022
Case Report: Primary Duodenal Melanoma with Brain MetastasisSonha Nguyen, Naila Khan, Christine Duong, et al.
Journal of General Internal Medicine|November 27, 2012
Test results follow-up: a systematic reviewShai Gavi, Vishal Ranpura, Sanjaykumar Hapani, et al.
American Journal of Hypertension|February 27, 2010
Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysisVishal Ranpura, Bhargava Pulipati, David Chu, et al.
Cureus|August 9, 2021
Transformation of Polycythemia Vera to Pure Erythroid LeukemiaLouisa Liu, Neil Dudheker, Lhara M Sumarriva Lezama, et al.
Cureus|February 1, 2022
Synchronous Bilateral Primary Testicular Tumors With Discordant HistopathologyLouisa Liu, Crystal Wang, Sameer Shah, et al.
Journal of Oncology Practice|February 19, 2015
Improving Documentation of Pain Management at MedStar Washington Cancer InstituteVishal Ranpura, Sundeep Agrawal, Puja Chokshi, et al.
Blood Advances|April 3, 2019
Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumabCatherine Lai, Vishal Ranpura, Colin Wu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JAMA|February 3, 2011
Treatment-related mortality with bevacizumab in cancer patients: a meta-analysisVishal Ranpura, Sanjaykumar Hapani, Shenhong Wu
Acta Oncologica (Stockholm, Sweden)|February 17, 2010
Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trialsVishal Ranpura, Sanjaykumar Hapani, Jeff Chuang, et al.
The Permanente Journal|March 29, 2022
Case Report: Primary Duodenal Melanoma with Brain MetastasisSonha Nguyen, Naila Khan, Christine Duong, et al.
Journal of General Internal Medicine|November 27, 2012
Test results follow-up: a systematic reviewShai Gavi, Vishal Ranpura, Sanjaykumar Hapani, et al.
American Journal of Hypertension|February 27, 2010
Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysisVishal Ranpura, Bhargava Pulipati, David Chu, et al.
Cureus|August 9, 2021
Transformation of Polycythemia Vera to Pure Erythroid LeukemiaLouisa Liu, Neil Dudheker, Lhara M Sumarriva Lezama, et al.
Cureus|February 1, 2022
Synchronous Bilateral Primary Testicular Tumors With Discordant HistopathologyLouisa Liu, Crystal Wang, Sameer Shah, et al.
Journal of Oncology Practice|February 19, 2015
Improving Documentation of Pain Management at MedStar Washington Cancer InstituteVishal Ranpura, Sundeep Agrawal, Puja Chokshi, et al.
Blood Advances|April 3, 2019
Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumabCatherine Lai, Vishal Ranpura, Colin Wu, et al.
Pageof 1